1 Benamer HT, Grosset DG. Vascular parkinsonism: aclinical review [J]. Eur Neurol, 2009, 61:11-15.2 T h a n v i B , L o N, R o b i n s o n T. Va s c u l a r-Parkinsonisman important cause of parkinsonism inolder people [J]. Age Ageing, 2005, 34:114-119.3 Rek t or I , Rek t orová I , Kub ová D. Va s cu l a rparkinsonism--an update[J]. J Neurol Sci, 2006,248:185-191.4 Zijlmans JC, Katzenschlager R, Daniel SE, et al. TheL-dopa response in vascular parkinsonism[J]. J NeurolNeurosurg Psychiatry, 2004, 75:545-547.5 Demirkiran M, Bozdemir H, Sarica Y. Vascularparkinsonism: a distinct, heterogeneous clinicalentity[J]. Acta Neurol Scand, 2001, 104:63-67.6 冯涛, 芦林龙, 李伟, 等. 血管性帕金森综合征的多巴反应性研究[J]. 中华老年心脑血管病杂志, 2007,9:42-44.7 Winikates J, Jankovic J. Clinical correlates of vascularparkinsonism[J]. Arch Neurol, 1999, 56:98-102.8 Gibb WR, Lees AJ. The relevance of the Lewybody to the pathogenesis of idiopathic Parkinson'sdisease[J]. J Neurol Neurosurg Psychiatry, 1988,51:745-752.9 Langston JW, Widner H, Goetz CG, et al. Coreassessment program for intracerebral transplantations(CAPIT)[J]. Mov Disord, 1992, 7:2-13.10 Feng T, Li W, Lu L, et al. Acute stepwise challenget e s t wi t h l evo dop a i n t r e a t e d p a t i e nt s wi t hparkinsonism[J]. Parkinsonism Relat Disord, 2009,5:354-358.11 Sibon I, Fenelon G, Quinn NP, et al. Vascularparkinsonism[J]. J Neurol, 2004, 251:513-524.12 Rampello L, Alvano A, Battaglia G, et al. Differentclinical and evolutional patterns in late idiopathicand vascular parkinsonism[J]. J Neurol, 2005,252:1045-1049.13 Zijlmans J, Evans A, Fontes F, et al. [123I] FP-CITspect study in vascular parkinsonism and Parkinson'sdisease[J]. Mov Disord, 2007, 22:1278-1285.14 Woitalla D, Goetze O, Kim JI, et al. Levodopaavailability improves with progression of Parkinson'sdisease[J]. J Neurol, 2006, 253:1221-1226.15 Marek K, Jennings D, Tamagnan G, et al. Biomarkersfor Parkinson's disease: tools to assess Parkinson'sdisease onset and progression[J]. Ann Neurol, 2008,64:s111-121. |